Muscle matters: Skeletal muscle index and body mass index impact on complications and survival in renal cancer

IF 1.6 Q3 UROLOGY & NEPHROLOGY
BJUI compass Pub Date : 2024-06-13 DOI:10.1002/bco2.405
Alexander Hintze Hillers, Signe Wang Bach, Atena Saito, Nessn Azawi
{"title":"Muscle matters: Skeletal muscle index and body mass index impact on complications and survival in renal cancer","authors":"Alexander Hintze Hillers,&nbsp;Signe Wang Bach,&nbsp;Atena Saito,&nbsp;Nessn Azawi","doi":"10.1002/bco2.405","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objective</h3>\n \n <p>The objective of this study is to independently assess skeletal muscle index (SMI) and body mass index (BMI) as prognostic determinants for renal cell carcinoma (RCC) and investigate their correlation with surgical outcomes.</p>\n </section>\n \n <section>\n \n <h3> Patients and methods</h3>\n \n <p>A retrospective cohort study of 524 RCC patients diagnosed between August 2010 and July 2018 was conducted using data from the Zealand University Hospital Renal Cancer Database in Denmark. Patient information was extracted from electronic patient records and the National Cancer Registry and encompassed demographics, clinical factors, tumour characteristics and surgical details. SMI was calculated from a single third lumbar vertebra (L3) axial computed tomography (CT) image via CoreSlicer software and classified into high using gender-specific thresholds. Primary outcomes focused on complications within 90 days as well as survival outcomes, and their relation with both SMI and BMI. Multivariable analysis assessed SMI's independent prognostic significance in RCC.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Among 524 patients, 18.5% experienced complications, with high SMI correlating significantly (<i>p</i> = 0.018) with a 72% higher complication risk. High SMI patients had a 22.7% complication rate compared to 14.5% in the low SMI group. High SMI was also linked to prolonged survival (110.95 vs. 94.87 months; <i>p</i> = 0.001), whereas BMI showed no significant survival differences (<i>p</i> = 0.326). Multivariable analysis (<i>n</i> = 522) revealed high SMI associated with improved survival (hazard ratio [HR] = 0.738; 95% CI, 0.548–0.994; <i>p</i> = 0.046). Advanced T-stage significantly impacted mortality (T2: HR = 2.057; T3: HR = 4.361; <i>p</i> &lt; 0.001), and each additional year of age raised mortality risk by 4.3% (HR = 1.043; <i>p</i> &lt; 0.001).</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Higher SMI increases the risk of postoperative complications, yet it significantly improves overall survival rates. Different BMI categories lack RCC prognostic significance. The increasing incidence in RCC calls for the use of CT scan to assess SMI and aid treatment planning in patients who might benefit from preoperative interventions.</p>\n </section>\n </div>","PeriodicalId":72420,"journal":{"name":"BJUI compass","volume":"5 8","pages":"783-790"},"PeriodicalIF":1.6000,"publicationDate":"2024-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/bco2.405","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BJUI compass","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/bco2.405","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

The objective of this study is to independently assess skeletal muscle index (SMI) and body mass index (BMI) as prognostic determinants for renal cell carcinoma (RCC) and investigate their correlation with surgical outcomes.

Patients and methods

A retrospective cohort study of 524 RCC patients diagnosed between August 2010 and July 2018 was conducted using data from the Zealand University Hospital Renal Cancer Database in Denmark. Patient information was extracted from electronic patient records and the National Cancer Registry and encompassed demographics, clinical factors, tumour characteristics and surgical details. SMI was calculated from a single third lumbar vertebra (L3) axial computed tomography (CT) image via CoreSlicer software and classified into high using gender-specific thresholds. Primary outcomes focused on complications within 90 days as well as survival outcomes, and their relation with both SMI and BMI. Multivariable analysis assessed SMI's independent prognostic significance in RCC.

Results

Among 524 patients, 18.5% experienced complications, with high SMI correlating significantly (p = 0.018) with a 72% higher complication risk. High SMI patients had a 22.7% complication rate compared to 14.5% in the low SMI group. High SMI was also linked to prolonged survival (110.95 vs. 94.87 months; p = 0.001), whereas BMI showed no significant survival differences (p = 0.326). Multivariable analysis (n = 522) revealed high SMI associated with improved survival (hazard ratio [HR] = 0.738; 95% CI, 0.548–0.994; p = 0.046). Advanced T-stage significantly impacted mortality (T2: HR = 2.057; T3: HR = 4.361; p < 0.001), and each additional year of age raised mortality risk by 4.3% (HR = 1.043; p < 0.001).

Conclusions

Higher SMI increases the risk of postoperative complications, yet it significantly improves overall survival rates. Different BMI categories lack RCC prognostic significance. The increasing incidence in RCC calls for the use of CT scan to assess SMI and aid treatment planning in patients who might benefit from preoperative interventions.

Abstract Image

肌肉很重要骨骼肌指数和体重指数对肾癌并发症和存活率的影响
本研究的目的是独立评估作为肾细胞癌(RCC)预后决定因素的骨骼肌指数(SMI)和体重指数(BMI),并调查它们与手术结果的相关性。本研究利用丹麦西兰大学医院肾癌数据库的数据,对2010年8月至2018年7月期间确诊的524名RCC患者进行了回顾性队列研究。患者信息来自电子病历和国家癌症登记处,包括人口统计学、临床因素、肿瘤特征和手术细节。SMI是通过CoreSlicer软件从单个第三腰椎(L3)轴向计算机断层扫描(CT)图像中计算出来的,并根据性别阈值将其分为高。主要结果侧重于 90 天内的并发症和生存结果,以及它们与 SMI 和 BMI 的关系。多变量分析评估了SMI在RCC中的独立预后意义。在524名患者中,18.5%出现了并发症,高SMI与72%的并发症风险显著相关(p = 0.018)。高SMI患者的并发症发生率为22.7%,而低SMI组为14.5%。高 SMI 也与生存期延长有关(110.95 个月 vs. 94.87 个月;p = 0.001),而 BMI 与生存期无显著差异(p = 0.326)。多变量分析(n = 522)显示,高 SMI 与生存期延长相关(危险比 [HR] = 0.738; 95% CI, 0.548-0.994; p = 0.046)。晚期T分期对死亡率有明显影响(T2:HR = 2.057;T3:HR = 4.361;p < 0.001),年龄每增加一岁,死亡风险就增加4.3%(HR = 1.043;p < 0.001)。不同的BMI分类对RCC预后没有意义。RCC发病率的增加要求使用CT扫描来评估SMI,并帮助可能受益于术前干预的患者制定治疗计划。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.30
自引率
0.00%
发文量
0
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信